An overview of benzo [b] thiophene-based medicinal chemistry
Among sulfur containing heterocycles, benzothiophene and its derivatives are at the focus
as these candidates have structural similarities with active compounds to develop new …
as these candidates have structural similarities with active compounds to develop new …
An overview of tubulin inhibitors that interact with the colchicine binding site
Tubulin dynamics is a promising target for new chemotherapeutic agents. The colchicine
binding site is one of the most important pockets for potential tubulin polymerization …
binding site is one of the most important pockets for potential tubulin polymerization …
[图书][B] Anticancer agents from natural products
GM Cragg, DGI Kingston, DJ Newman - 2005 - taylorfrancis.com
Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …
and signaling systems that are designed to protect them from predators and provide other …
Iodine-mediated synthesis of heterocycles via electrophilic cyclization of alkynes
T Aggarwal, S Kumar, AK Verma - Organic & biomolecular chemistry, 2016 - pubs.rsc.org
Iodine has been recognized as an efficient, non-toxic, readily available and easy-to-handle
electrophilic reagent to favour halocyclization reactions for the synthesis of novel …
electrophilic reagent to favour halocyclization reactions for the synthesis of novel …
Spectroscopic, theoretical and computational investigations of novel benzo [b] thiophene based ligand and its M (II) complexes: As high portentous antimicrobial and …
NG Yernale, BS Mathada, S Shivprasad… - … Acta Part A: Molecular …, 2023 - Elsevier
The reaction of 3-chlorobenzo [b] thiophene-2-carbohydrazide with 4-(diethylamino)
salicylaldehyde gave the new ligand; 3-chloro-N'-(4-(diethylamino)-2-hydroxybenzylidene) …
salicylaldehyde gave the new ligand; 3-chloro-N'-(4-(diethylamino)-2-hydroxybenzylidene) …
Synthesis, single crystal, characterization and computational study of 2-amino-N-cyclopropyl-5-ethyl-thiophene-3-carboxamide
G Khanum, A Fatima, N Siddiqui, DD Agarwal… - Journal of Molecular …, 2022 - Elsevier
amino-N-cyclopropyl-5-ethylthiophene-3-carboxamide (ACPETC)(C 10 H 14 N 2 OS) has
been synthesized, characterized via single-crystal X-ray diffraction at 296 K and studied …
been synthesized, characterized via single-crystal X-ray diffraction at 296 K and studied …
CuI/TMEDA-Catalyzed Annulation of 2-Bromo Alkynylbenzenes with Na2S: Synthesis of Benzo[b]thiophenes
LL Sun, CL Deng, RY Tang… - The Journal of Organic …, 2011 - ACS Publications
A copper-catalyzed thiolation annulation reaction of 2-bromo alkynylbenzenes with sodium
sulfide has been developed. In the presence of CuI and TMEDA, a variety of 2-substituted …
sulfide has been developed. In the presence of CuI and TMEDA, a variety of 2-substituted …
Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity
Since microtubules have an important role in mitosis and other vital cellular functions,
tubulin-targeting chemotherapy has been received growing attention in anticancer drug …
tubulin-targeting chemotherapy has been received growing attention in anticancer drug …
[PDF][PDF] Antimitotic chalcones and related compounds as inhibitors of tubulin assembly
S Ducki - Anti-cancer agents in medicinal chemistry, 2009 - researchgate.net
The development of chalcones as antimitotic agents has led to the design of other
analogues able to interact with tubulin and inhibit its assembly into microtubules. This …
analogues able to interact with tubulin and inhibit its assembly into microtubules. This …
[HTML][HTML] Recent advances and SAR study of 2-substituted benzothiazole scaffold based potent chemotherapeutic agents
In recent times cancer has become one of the leading causes of death. Globally around 11
million deaths are reported every year due to cancer. Some clinically approved anticancer …
million deaths are reported every year due to cancer. Some clinically approved anticancer …